Understanding CDK4/6 inhibitors

ADVERTORIAL BY LILLY The management of advanced breast cancer continues to evolve, particularly in the frontline setting. To boost the success of endocrine therapies, cyclin-dependent...

Australia’s youngest next to receive COVID-19 vaccine

With the COVID-19 vaccine for children aged 6 months to 5 years given the green light in the United States, Moderna’s Chief Medical Officer Dr Paul Burton expects the infant vaccine to roll out in Australia next month.

The role of pharmacists in travel vaccination

Many travellers delay vaccinations due to costs and access issues. Pharmacists play a vital role in providing preventive care.

Updated heart failure and atrial fibrillation guidelines

New guidelines on heart failure and atrial fibrillation have been released, including new pharmacological recommendations. Released by the National Heart Foundation of Australia (NHF) in...

The policymaker

Karen Castle MPS, PSA’s newest policy pharmacist, writes healthcare legislation and knows plenty about voluntary assisted dying requirements.

Comorbid insomnia and sleep apnoea (COMISA)

Comorbid insomnia and sleep apnoea is a debilitating condition that requires nuanced assessment and management approaches.